Search research articles
Contact Us
Filters
Showing results (21-30 of 179) with videos related to
Page
of 18
Sort By:
Targeted Oncology
|
October 4, 2023
EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
Xiuning Le, Eric Nadler, Daniel B Costa, et al.
Targeted Oncology
|
October 27, 2023
Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
Xiuning Le, Eric Nadler, Daniel B Costa, et al.
Targeted Oncology
|
December 9, 2023
Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
Xiuning Le, Eric Nadler, Daniel B Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2025
Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results
Xiuning Le, Mike Hernandez, Simon Heeke, et al.
Surgical Oncology Clinics of North America
|
September 5, 2020
Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer
Boris Sepesi, Tina Cascone, Stephen G Chun, et al.
Current Oncology Reports
|
March 7, 2020
Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Sonam Puri, Andreas Saltos, Bradford Perez, et al.
Cancer Cell
|
August 13, 2021
ARTEMIS highlights VEGF inhibitors as effective partners for EGFR TKIs in EGFR mutant NSCLC
Xiuning Le, Monique B Nilsson, Jacqulyne P Robichaux, et al.
Therapeutic Advances in Medical Oncology
|
November 1, 2024
Targeting the MET gene: unveiling therapeutic opportunities in immunotherapy within the tumor immune microenvironment of non-small cell lung cancer
Lisha Ye, Wenjing Wang, Huihui Li, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 1, 2024
New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on <i>EGFR</i>-Mutant Tumors
Stephanie P L Saw, Xiuning Le, Lizza E L Hendriks, et al.
NPJ Precision Oncology
|
January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?
Niamh Coleman, Timothy A Yap, John V Heymach, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 179) with videos related to
Sort By:
Page
of 18
Targeted Oncology
|
October 4, 2023
EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
Xiuning Le, Eric Nadler, Daniel B Costa, et al.
Targeted Oncology
|
October 27, 2023
Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
Xiuning Le, Eric Nadler, Daniel B Costa, et al.
Targeted Oncology
|
December 9, 2023
Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
Xiuning Le, Eric Nadler, Daniel B Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2025
Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results
Xiuning Le, Mike Hernandez, Simon Heeke, et al.
Surgical Oncology Clinics of North America
|
September 5, 2020
Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer
Boris Sepesi, Tina Cascone, Stephen G Chun, et al.
Current Oncology Reports
|
March 7, 2020
Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Sonam Puri, Andreas Saltos, Bradford Perez, et al.
Cancer Cell
|
August 13, 2021
ARTEMIS highlights VEGF inhibitors as effective partners for EGFR TKIs in EGFR mutant NSCLC
Xiuning Le, Monique B Nilsson, Jacqulyne P Robichaux, et al.
Therapeutic Advances in Medical Oncology
|
November 1, 2024
Targeting the MET gene: unveiling therapeutic opportunities in immunotherapy within the tumor immune microenvironment of non-small cell lung cancer
Lisha Ye, Wenjing Wang, Huihui Li, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 1, 2024
New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on <i>EGFR</i>-Mutant Tumors
Stephanie P L Saw, Xiuning Le, Lizza E L Hendriks, et al.
NPJ Precision Oncology
|
January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?
Niamh Coleman, Timothy A Yap, John V Heymach, et al.
Page
of 18